Concordia Healthcare Corp (TSE:CXR) (NASDAQ:CXRX)‘s stock had its “sector perform” rating reiterated by investment analysts at Royal Bank Of Canada in a report released on Monday, reports.

Other equities analysts have also issued research reports about the company. Goldman Sachs Group Inc. dropped their target price on Concordia Healthcare Corp from C$34.00 to C$17.00 in a report on Monday, August 15th. Bloom Burton reaffirmed a “hold” rating on shares of Concordia Healthcare Corp in a report on Wednesday, October 26th. TD Securities raised their price objective on Concordia Healthcare Corp from C$7.00 to C$14.00 and gave the stock a “hold” rating in a report on Monday, September 19th. Finally, CIBC lowered Concordia Healthcare Corp from a “sector perform” rating to an “underperform” rating in a report on Monday, August 15th. Two research analysts have rated the stock with a sell rating and four have assigned a hold rating to the company’s stock. Concordia Healthcare Corp presently has an average rating of “Hold” and an average target price of C$26.13.

Analyst Recommendations for Concordia Healthcare Corp (TSE:CXR)

Concordia Healthcare Corp (TSE:CXR) opened at 3.47 on Monday. The stock’s market cap is $177.03 million. Concordia Healthcare Corp has a 52 week low of $2.27 and a 52 week high of $28.35. The company has a 50 day moving average price of $4.40 and a 200 day moving average price of $17.22.

WARNING: This piece of content was originally published by The Cerbat Gem and is the propert of of The Cerbat Gem. If you are viewing this piece of content on another publication, it was illegally copied and reposted in violation of U.S. and international copyright and trademark law. The correct version of this piece of content can be accessed at

About Concordia Healthcare Corp

Stock Target Prices

Receive News & Stock Ratings for Concordia Healthcare Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Concordia Healthcare Corp and related stocks with our FREE daily email newsletter.